CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

← CITY THERAPEUTICS, INC. (CTY) — catalysts, pipeline & price
Catalyst Dossier · compiled by CeliA 🧫

CITY THERAPEUTICS, INC. (CTY)

Biotechnology · market cap $1.1B

Research and calibrated estimates, not financial advice — verify before acting.

Next catalyst
None scheduled
Pipeline
9
programs
Upcoming events
0
next 90d+
Dossier
Not yet
generate it
The catalyst path

No upcoming catalysts in our calendar.

Pipeline
AssetPhaseIndication
PLA (Panto+Levoflox+Azithro)Phase 3Helicobacter Pylori Gastritis
TB/Flu-05EPhase 2Tuberculosis
High-Dose Melphalan HCL for Injection (Propylene Glycol-Free)Phase 2Multiple Myeloma
Therapeutic AnticoagulationPhase 3COVID-19
VivarinPhase 2Narcolepsy
DiacetylmorphinePhase 3Opioid Dependence
RSV/Flu-01EPhase 2Respiratory Synctial Virus Infections
Cal-Mag ButyratePhase 2Gulf War Illness
Combination of Palbociclib and aromatase inhibitor (Letrozole or Anastrozole)Phase 2Hormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer
Price & technical context
3-month
—
6-month
—
12-month
—
52-wk range
$16.41–$22.40
vs 50-day MA
—
vs 200-day MA
—
Realized vol
99.6%
Max drawdown
-26.7%

Daily closes through 2026-11-17. Realized vol annualized; max drawdown over ~2 years.

The full dossier is a Pro feature

Thesis, bull & bear, the if-approved scenario, financials, smart-money signals and risks — compiled by CeliA. The catalyst path & pipeline above are free.

Sources & data
  • SEC filings — EDGAR filings for CTY (10-K, 10-Q, S-3, 13D/G, Form 4)
  • Clinical trials — 9 registered trials on ClinicalTrials.gov (per-trial NCT links in the pipeline)
  • Market & financial data — SEC EDGAR (XBRL filings, Form 4), Yahoo Finance, Nasdaq — prices, statements, key metrics, insider & institutional filings.
  • Regulatory — openFDA, FDA advisory & PDUFA calendars.

Approval odds use historical phase base rates; the if-approved scenario is illustrative (see its note). Figures trace to the sources above — verify before acting.

Data from CatalystAlert (ClinicalTrials.gov, SEC EDGAR, openFDA, market-data providers). Compiled by CeliA. Not financial advice.